The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Lethality of Multiple Endocrine Neoplasia Type I
Abstract
The lethality of the endocrine tumors associated with multiple endocrine neoplasia type I (MEN‐I), particularly the pancreatic islet cell tumors, has been controversial. We evaluated the cause and age of death in MEN‐I kindreds. Our database contains 34 distinct kindreds with 1838 members. Reliable death data are available for 103 people (excluding accidents and age < 18 years). We compared survival curves of MEN‐I patients who died from causes related to MEN‐I with those from MEN‐I carriers who died from a nonendocrine cause and unaffected kindred members. We also compared ages of death between affected and unaffected members of MEN‐I kindreds. Of 59 MEN‐I‐affected patients, 27 died directly of MEN‐I‐specific illness and 32 of non‐MEN‐I causes. The MEN‐I‐specific deaths occurred at a younger age (median 47 years) than either MEN‐I patients whose death was from some nonendocrine cause (median 60 years, p < 0.02) or than all kindred members who did not die of MEN‐I disease (median 55 years,p < 0.05). The causes of death of the MEN‐I patients included islet cell tumor (n= 12), ulcer disease (n= 6), hypercalcemia/uremia (n= 3), carcinoid tumor (n= 6), and nonendocrine malignancies (n= 9). There was no difference in survival between MEN‐I carriers and unaffected kindred members. Of our MEN‐I patients, 46% died from causes related to their endocrine tumors after a median age of 47 years, which was younger than family members who did not die from these tumors. Pancreatic islet cell tumors were the most common cause of death of MEN‐I patients. Management of kindreds with MEN‐I should include an aggressive screening program with early therapeutic intervention when a tumor is identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Genetic aspects of adenomatosis of endocrine glands
Wermer, P. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90353-8 · Cited by 860
Weber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Self-citationMultiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*
SKOGSEID, B., ERIKSSON, B., LUNDQVIST, G., LÖRELIUS, L.-E., RASTAD, J., WIDE, L., ÅKERSTRÖM, G., & ÖBERG, K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-281 · Cited by 232
Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study.
Sheppard, B. C., Norton, J. A., Doppman, J. L., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1989) · PubMed · Cited by 156
Self-citationCause of Death in Multiple Endocrine Neoplasia Type 1
Wilkinson, S. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420180085016 · Cited by 151
Surgery for Asymptomatic Pancreatic Lesion in Multiple Endocrine Neoplasia Type I
Skogseid, B. M., Öberg, K., Eriksson, B., Juhlin, C. C., Granberg, D. O., Åkerström, G., & Rastad, J. (1996) · World Journal of Surgery · doi:10.1007/s002689900133 · Cited by 113
Mignon, M., Ruszniewski, P. B., Podevin, P., Sabbagh, L. C., Cadiot, G., Rigaud, D., & Bonfils, S. (1993) · World Journal of Surgery · doi:10.1007/bf01655108 · Cited by 109
Multiple Endocrine Neoplasia Type 1: Clinical Features and Screening
Skogseid, B. M., Rastad, J., & Öberg, K. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30112-9 · Cited by 103
Latent familial multiple endocrine neoplasia in Tasmania
Shepherd, J. J. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb133152.x · Cited by 38
Cited by
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Lemos, M. C., & Thakker, R. V. (2008) · Human Mutation · doi:10.1002/humu.20605 · Cited by 675
Jensen, R. T., Berna, M. J., Bingham, D. B., & Norton, J. A. (2008) · Cancer · doi:10.1002/cncr.23648 · Cited by 488
Self-citationPancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Halfdanarson, T. R., Rubin, J., Farnell, M. B., Grant, C. S., & Petersen, G. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0221 · Cited by 372
Metadata
- Authors
- Doherty, G. M., Olson, J. A., Frisella, M. M., Lairmore, T. C., Wells, S. A., & Norton, J. A.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 1998-06
- Volume
- 22
- Issue
- 6
- Pages
- 581-587
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2043976069
- Cited by
- 252
- References
- 11
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lethality of Multiple Endocrine Neoplasia Type I. https://app.cochat.ai/papers/10.1007/s002689900438
- The paper
- Doherty, G. M., Olson, J. A., Frisella, M. M., Lairmore, T. C., Wells, S. A., & Norton, J. A. (1998). Lethality of Multiple Endocrine Neoplasia Type I. World Journal of Surgery. https://doi.org/10.1007/s002689900438
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.